General Information of the Compound
| Compound ID |
CP0568492
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[6-[5-[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]pyrazin-2-yl]oxy-1-methylindol-2-yl]-[4-[[4-(2,2,2-trifluoroethoxy)phenyl]methyl]piperazin-1-yl]methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C36H32F3N7O5
|
||||||||||||||||||
| Molecular Weight |
699.69
|
||||||||||||||||||
| Canonical SMILES |
COc1cccc(c1)-c1noc(n1)-c1cnc(Oc2ccc3cc(C(=O)N4CCN(Cc5ccc(OCC(F)(F)F)cc5)CC4)n(C)c3c2)cn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C36H32F3N7O5/c1-44-30-18-28(50-32-20-40-29(19-41-32)34-42-33(43-51-34)25-4-3-5-27(16-25)48-2)11-8-24(30)17-31(44)35(47)46-14-12-45(13-15-46)21-23-6-9-26(10-7-23)49-22-36(37,38)39/h3-11,16-20H,12-15,21-22H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
VGAZMJZXQCZEPG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound